Is Clinical Decision-Making (CDS) Software Expanded or More Legally Ambiguous under the CURES Act?
The CURES Act codifies the way FDA has regulated clinical decision-making software, but is this better or worse for healthcare startups that are trying to position their software within the CDS model?
